CTC Blauspray

CTC Blauspray may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for CTC Blauspray

Chlortetracycline

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of CTC Blauspray in the following countries:

• Germany

International Drug Name Search

Reuprofen

Reuprofen may be available in the countries listed below.

Ingredient matches for Reuprofen

Ibuprofen

Ibuprofen is reported as an ingredient of Reuprofen in the following countries:

• Romania

Ketoprofen

Ketoprofen is reported as an ingredient of Reuprofen in the following countries:

• Italy

International Drug Name Search

Dextropropoxyphène Paracétamol CristerS

Dextropropoxyphène Paracétamol CristerS may be available in the countries listed below.

Ingredient matches for Dextropropoxyphène Paracétamol CristerS

Dextropropoxyphene

Dextropropoxyphene hydrochloride (a derivative of Dextropropoxyphene) is reported as an ingredient of Dextropropoxyphène Paracétamol CristerS in the following countries:

• France

Paracetamol

Paracetamol is reported as an ingredient of Dextropropoxyphène Paracétamol CristerS in the following countries:

• France

International Drug Name Search

Bupivacaina

Bupivacaina may be available in the countries listed below.

Ingredient matches for Bupivacaina

Bupivacaine

Bupivacaina (DCIT) is known as Bupivacaine in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Butrans Patch

Pronunciation: BUE-pre-NOR-feen
Generic Name: Buprenorphine
Brand Name: Butrans

Butrans Patch is a narcotic analgesic used to manage moderate to severe chronic pain in patients who need continuous, around-the-clock narcotic pain relief for an extended period of time. It should not be used to treat occasional pain.

Do NOT take more than the recommended dose without checking with your doctor. Taking more than the recommended dose may increase your risk of irregular heartbeat.

Do not expose the patch to direct sources of heat, such as heating pads, electric blankets, heat lamps, saunas, hot tubs, or heated waterbeds. Avoid sunbathing; long, hot baths; or other sources of heat to the body. The heat may cause more medicine to be released into your skin and could cause serious, even fatal, side effects.

Butrans Patch is used for:

Managing moderate to severe chronic pain in patients who need continuous, around-the-clock narcotic (opioid) pain relief for an extended period of time.

Butrans Patch is a narcotic (opioid) analgesic. It works by binding to receptors in the brain and nervous system to decrease pain.

Do NOT use Butrans Patch if:

• you are allergic to any ingredient in Butrans Patch


• you have very slow or difficult breathing, severe asthma, or severe lung problems


• you have known or suspected bowel blockage (eg, paralytic ileus) or severe or persistent diarrhea caused by antibiotics


• you have mild or short-term pain or pain that occurs after surgery


• you do not need to take pain medicine on a regular basis


• you are taking sodium oxybate (GHB) or you have taken a monoamine oxidase inhibitor (MAOI) (eg, furazolidone, phenelzine) within the past 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Butrans Patch:

Some medical conditions may interact with Butrans Patch. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription, especially narcotic pain medicines (eg, oxycodone, morphine), or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of blood electrolyte problems (eg, low blood potassium levels); breathing or lung problems (eg, chronic obstructive pulmonary disease [COPD], asthma, sleep apnea); obesity; thyroid problems (eg, myxedema, an underactive thyroid); curvature of the spine; adrenal gland problems (eg, Addison disease); liver problems (eg, hepatitis B or C); skin reactions to adhesives; seizures; kidney problems; pancreas problems; prostate problems (eg, enlarged prostate gland); trouble urinating; a blockage of your bladder, bowel, stomach, or urethra; gallbladder problems; bowel problems (eg, constipation, inflammatory bowel disease); stomach problems; or recent bladder, bowel, or stomach surgery


• if you have a history of heart problems (eg, cor pulmonale, heart failure), heart rhythm problems (eg, atrial fibrillation, slow heartbeat), a recent heart attack, or if you or a family member has a history of long QT syndrome


• if you have a history of a recent head injury, growths in the brain (eg, tumor, lesion), increased pressure in the brain, or muscle problems (eg, myasthenia gravis)


• if you have a fever, low blood pressure, low blood volume, severe drowsiness, or slow or shallow breathing


• if you have a history of mental or mood problems (eg, depression, hallucinations), narcotic dependence, are in alcohol withdrawal, or if you or a family member has a history of alcohol or substance abuse


• if you are taking an antiarrhythmic medicine (eg, quinidine, sotalol, amiodarone)

Some MEDICINES MAY INTERACT with Butrans Patch. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Antiarrhythmics (eg, amiodarone, quinidine, sotalol), azole antifungals (eg, ketoconazole, voriconazole), HIV protease inhibitors (eg, atazanavir, ritonavir), or phenothiazines (eg, chlorpromazine) because they may increase the risk of Butrans Patch's side effects


• Benzodiazepines (eg, diazepam), cimetidine, narcotic pain medicine (eg, codeine), phenothiazines (eg, chlorpromazine), skeletal muscle relaxants (eg, cyclobenzaprine), or sodium oxybate ( GHB) because the risk of severe drowsiness, severe breathing problems, and seizures may be increased


• Carbamazepine, naltrexone, phenobarbital, phenytoin, or rifamycins (eg, rifampin) because they may decrease Butrans Patch's effectiveness


• MAOIs (eg, phenelzine) because the risk of their side effects may be increased by Butrans Patch


• Methadone because its effectiveness may be decreased by Butrans Patch


• Medicines that may harm the liver (eg, acetaminophen, isoniazid, ketoconazole, certain medicines for HIV infection, methotrexate) because the risk of liver side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver

This may not be a complete list of all interactions that may occur. Ask your health care provider if Butrans Patch may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Butrans Patch:

Use Butrans Patch as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Butrans Patch comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Butrans Patch refilled.


• Do not use Butrans Patch if the pouch seal is broken or if the patch is cut, damaged, or changed in any way.


• Keep Butrans Patch in its original package until you are ready to use it. Apply the patch as soon as you remove it from the sealed pouch.


• Butrans Patch is only to be used on intact, clean, dry skin. Do not apply Butrans Patch to broken, damaged, or inflamed skin.


• The application site should be hairless or nearly hairless. If you have no hairless areas, clip the hair; do NOT shave it. If the application site must be cleaned, clean the site with clear water only. Do NOT clean the area with soap, alcohol, lotion, oil, or other cleansers because the risk of Butrans Patch's side effects may be increased. Allow the skin to dry before you apply the patch.


• Apply the patch to the upper outer arm, upper chest, upper back, or the side of your chest on either side of your body. Do not apply a new patch to the same skin area for at least 21 days. Do not wear more than 1 patch at a time unless your doctor tells you otherwise.


• Press the patch firmly in place with the palm of your hand for about 15 seconds. Do not rub the patch. Make sure the contact is complete, especially around the edges. Wash your hands after you apply or handle a patch.


• If the patch does not stick, you may tape only the edges with first-aid tape or cover the patch with a special type of clear adhesive film dressing (eg, Bioclusive, Tegaderm). Do not cover the patch with any other bandage or tape. Ask your doctor or pharmacist about the kinds of dressings that should be used.


• If the patch falls off, do NOT re-apply it. Apply a new patch to a different skin site.


• A patch may be worn continuously for 1 week (exactly 7 days) or as directed by your doctor. After removing the old patch, a new patch may be applied to a different skin site.


• After removing the used patch, fold it in half with the sticky sides together. Flush the used patch down the toilet. You can also use the patch-disposal unit to seal the used patch. Never throw Butrans Patch away if it is not sealed in the patch-disposal unit. Discard the patch out of the reach of children and away from pets.


• If you forget to change your patch on the day it is due, change the patch as soon as you remember. Do NOT double your dose to catch up.

Ask your health care provider any questions you may have about how to use Butrans Patch.

Important safety information:

• Butrans Patch may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Butrans Patch with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Butrans Patch; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Butrans Patch may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor. Do not change the patch more often than directed by your doctor.


• Butrans Patch may cause withdrawal symptoms if you have a physical dependence on narcotic medicines (eg, morphine) or other opiates (eg, heroin). Talk with your doctor if you are dependent on narcotic medicines or other opiates.


• Do not expose the patch on your skin to direct sources of heat, such as heating pads, electric blankets, heat or tanning lamps, saunas, hot tubs, or heated waterbeds. Avoid sunbathing; long, hot baths; or other sources of heat to the body. Tell your doctor if you develop a fever. The heat may cause more medicine to be released into your skin.


• If the patch comes off your skin and accidentally sticks to the skin of another person, remove the patch from their skin immediately, wash the exposed area of skin with water, and call your doctor, emergency room, or local poison control center right away.


• Butrans Patch may cause constipation. Talk with your doctor about taking a stool softener or fiber laxative to prevent or treat constipation.


• Tell your doctor or dentist that you take Butrans Patch before you receive any medical or dental care, emergency care, or surgery.


• Lab tests, including liver function, may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.


• Use Butrans Patch with caution in the ELDERLY; they may be more sensitive to its effects, especially decreased breathing and drowsiness.


• Butrans Patch should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Butrans Patch, discuss with your doctor the benefits and risks of using Butrans Patch during pregnancy. Butrans Patch is found in breast milk. Do not breast-feed while taking Butrans Patch.

When used for long periods of time or at high doses, Butrans Patch may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Butrans Patch stops working well. Do not take more than prescribed.

Some people who use Butrans Patch for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.

Do not suddenly stop taking Butrans Patch. If you do, you may experience WITHDRAWAL symptoms including anxiety; back, muscle, or joint pain; chills; diarrhea; enlarged pupils; fainting; irritability; runny nose; goose bumps and abnormal skin sensations; increased tearing; muscle or stomach cramps; nausea; pain; persistent loss of appetite; rapid heartbeat or breathing; restlessness; severe or persistent headache; sweating; trouble sleeping; vomiting; weakness; and yawning.

Possible side effects of Butrans Patch:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; dizziness; drowsiness; dry mouth; fatigue; headache; itching, rash, or redness at the application site; nausea; sweating; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal sighing or snoring; burning, swelling, oozing, or blisters at the application site; chest pain; confusion; dark urine; difficult, shallow, or slow breathing; difficulty talking, thinking, or walking; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; joint or muscle pain; loss of consciousness; mental or mood changes (eg, anxiety, depression); pale stools; seizures; severe drowsiness, dizziness, or lightheadedness; severe or persistent headache or stomach pain; shortness of breath; swelling of the hands, ankles, or feet; tremor; unusual weakness; vision changes; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Butrans side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include abnormal snoring; cold and clammy skin; excessive drowsiness; fainting; irregular heartbeat; loss of consciousness; muscle weakness; severe dizziness; slow heartbeat; very slow and shallow breathing; very small pupils.

Proper storage of Butrans Patch:

Store Butrans Patch at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store in original packaging until just before use. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Butrans Patch out of the reach of children and away from pets.

General information:

• If you have any questions about Butrans Patch, please talk with your doctor, pharmacist, or other health care provider.


• Butrans Patch is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Butrans Patch. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Butrans resources

• Butrans Side Effects (in more detail)
• Butrans Use in Pregnancy & Breastfeeding
• Butrans Drug Interactions
• Butrans Support Group
• 29 Reviews for Butrans - Add your own review/rating

Compare Butrans with other medications

• Pain

Rowasa Enema

Pronunciation: me-SAL-a-meen
Generic Name: Mesalamine
Brand Name: Rowasa

Rowasa Enema is used for:

Treating mild to moderate inflammation of the colon or rectum.

Rowasa Enema is a 5-aminosalicylic acid (5-ASA). It works by preventing the production of substances that cause the inflammation of the colon.

Do NOT use Rowasa Enema if:

• you are allergic to any ingredient in Rowasa Enema, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen, naproxen), or salicylates (eg, aspirin)


• you are younger than 18 years of age and you have the flu or chickenpox, or you have received a live vaccine (eg, varicella, influenza) within the past 6 weeks


• you are taking probenecid or sulfinpyrazone

Contact your doctor or health care provider right away if any of these apply to you.

Before using Rowasa Enema:

Some medical conditions may interact with Rowasa Enema. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines (including sulfasalazine), foods, or other substances (including sulfites)


• if you have had a stroke, bleeding in the brain, or an aneurysm


• if you have a history of liver or kidney problems, pancreas problems (eg, pancreatitis), Kawasaki syndrome, or a rheumatic (inflammatory) disease (eg, rheumatoid arthritis)


• if you have a history of heart problems (eg, inflammation of the sac around your heart)


• if you have the flu or chickenpox, or if you have recently received a live vaccine (eg, varicella, influenza)

Some MEDICINES MAY INTERACT with Rowasa Enema. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Gingko biloba extract because side effects, such as increased bleeding, may occur


• Corticosteroids (eg, prednisone) because they may decrease Rowasa Enema's effectiveness


• Carbonic anhydrase inhibitors (eg, acetazolamide), insulin, meglitinide antidiabetics (eg, repaglinide), sulfonylureas (eg, glipizide), or valproic acid because the risk of their side effects may be increased by Rowasa Enema


• Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril), anticoagulants (eg, warfarin), beta-blockers (eg, propranolol), probenecid, spironolactone, or sulfinpyrazone because their effectiveness may be decreased by Rowasa Enema

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rowasa Enema may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Rowasa Enema:

Use Rowasa Enema as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Best results are achieved if the bowel is emptied immediately before using Rowasa Enema.


• Use Rowasa Enema at bedtime, unless otherwise directed by your doctor.


• Shake the bottle well. Remove the protective sheath from the applicator tip.


• Holding the bottle at the neck will not allow the medicine to be discharged. The position most often used is to lay on the left side, with the lower leg extended and the upper right leg flexed forward for balance. An alternative is the knee-chest position.


• Gently insert the applicator tip in the rectum, pointing toward the naval. Grasp the bottle firmly, then tilt slightly so that the nozzle is aimed toward the back. Squeeze slowly to instill the medicine. Steady hand pressure will discharge most of the medicine. After using, withdraw the bottle and throw it away.


• Remain in this position for at least 30 minutes after using Rowasa Enema to allow complete distribution of the medicine in the body. Retain Rowasa Enema all night if possible.


• Rowasa Enema will stain direct contact surfaces, including fabrics, flooring, painted surfaces, marble, granite, vinyl, and enamel. Choose a suitable location when using Rowasa Enema.


• If you miss a dose of Rowasa Enema and you are using 1 dose daily at bedtime, skip the missed dose. Do not use the dose in the morning. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Rowasa Enema.

Important safety information:

• Rowasa Enema may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Rowasa Enema with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Rowasa Enema may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Rowasa Enema. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Some of these products contain sulfites. Sulfites may cause an allergic reaction in some patients (eg, asthma patients). If you have ever had an allergic reaction to sulfites, ask your pharmacist if your product has sulfites in it.


• Some patients may experience an intolerance reaction to Rowasa Enema. Signs of intolerance are very similar to symptoms of inflammatory bowel disease. They may include bloody diarrhea, fever, headache, rash, or severe or persistent stomach pain or cramping. If you experience any of these symptoms, contact your doctor right away.


• Salicylates have been linked to a serious illness called Reye syndrome. Do not give Rowasa Enema to a child or teenager who has the flu, chickenpox, or a viral infection. Contact your doctor with any questions or concerns.


• Lab tests, including kidney function, liver function, or complete blood cell counts, may be performed while you use Rowasa Enema. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Rowasa Enema with caution in the ELDERLY; they may be more sensitive to its effects, especially blood problems.


• Rowasa Enema should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rowasa Enema while you are pregnant. It is not known if Rowasa Enema is found in breast milk. If you are or will be breast-feeding while you use Rowasa Enema, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Rowasa Enema:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Flu-like symptoms; gas; hemorrhoids; mild headache; mild stomach discomfort or pain; nausea; rectal pain.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); back, leg, or joint pain; bloody or coffee ground-like vomit; chest pain; dark urine; dark, bloody, or tarry stools; fever, chills, or persistent sore throat; hair loss; severe headache; shortness of breath; sudden or severe stomach pain or cramping; unusual bruising or bleeding; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Rowasa side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; diarrhea; dizziness; drowsiness; fast or difficult breathing; fever; headache; hearing loss; ringing in the ears; seizures; sweating; vomiting of blood; weakness.

Proper storage of Rowasa Enema:

Store Rowasa Enema between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. After the foil-wrapped unit of 7 bottles is opened, use all enemas promptly. The contents of the enemas may darken with time. Slight darkening will not affect the strength of Rowasa Enema. Throw away enemas with dark brown contents. Keep Rowasa Enema out of the reach of children and away from pets.

General information:

• If you have any questions about Rowasa Enema, please talk with your doctor, pharmacist, or other health care provider.


• Rowasa Enema is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rowasa Enema. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rowasa resources

• Rowasa Side Effects (in more detail)
• Rowasa Use in Pregnancy & Breastfeeding
• Rowasa Drug Interactions
• Rowasa Support Group
• 5 Reviews for Rowasa - Add your own review/rating

Compare Rowasa with other medications

• Crohn's Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis
• Ulcerative Colitis, Active
• Ulcerative Proctitis

Calcipotriolo Sandoz

Calcipotriolo Sandoz may be available in the countries listed below.

Ingredient matches for Calcipotriolo Sandoz

Calcipotriol

Calcipotriol is reported as an ingredient of Calcipotriolo Sandoz in the following countries:

• Italy

International Drug Name Search

Roxamed

Roxamed may be available in the countries listed below.

Ingredient matches for Roxamed

Roxithromycin

Roxithromycin is reported as an ingredient of Roxamed in the following countries:

• Bahrain


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Nigeria


• Oman


• Qatar


• Romania


• Saudi Arabia


• Somalia


• Sudan


• Tunisia


• United Arab Emirates


• Yemen

International Drug Name Search

Bisadynam

Bisadynam may be available in the countries listed below.

Ingredient matches for Bisadynam

Bisacodyl

Bisacodyl is reported as an ingredient of Bisadynam in the following countries:

• Peru

International Drug Name Search

Claritromicina Teva

Claritromicina Teva may be available in the countries listed below.

Ingredient matches for Claritromicina Teva

Clarithromycin

Clarithromycin is reported as an ingredient of Claritromicina Teva in the following countries:

• Italy

International Drug Name Search

Cetirizin EP

Cetirizin EP may be available in the countries listed below.

Ingredient matches for Cetirizin EP

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizin EP in the following countries:

• Hungary

International Drug Name Search

Bifantrel

Bifantrel may be available in the countries listed below.

Ingredient matches for Bifantrel

Pyrantel

Pyrantel is reported as an ingredient of Bifantrel in the following countries:

• Colombia

International Drug Name Search

Cromo-Asma

Cromo-Asma may be available in the countries listed below.

Ingredient matches for Cromo-Asma

Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Cromo-Asma in the following countries:

• Peru

International Drug Name Search

Bifonazole

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D01AC10

CAS registry number (Chemical Abstracts Service)

0060628-96-8

Chemical Formula

C22-H18-N2

Molecular Weight

310

Therapeutic Category

Antifungal agent for topical use

Chemical Name

1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-

Foreign Names

• Bifonazolum (Latin)
• Bifonazol (German)
• Bifonazole (French)
• Bifonazol (Spanish)

Generic Names

• Bifonazole (OS: BAN, USAN, JAN, DCF)
• Bifonazolo (OS: DCIT)
• Bay h 4502 (IS: Bayer)
• Bifonazol (PH: Ph. Eur. 6)
• Bifonazole (PH: BP 2010, JP XV, Ph. Eur. 6)
• Bifonazolum (PH: Ph. Eur. 6)

Brand Names

• Agispor
  Agis, Israel



• Aicozale
  Fuji Yakuhin, Japan



• Amycor Onychoset (Bifonazole and Urea)
  Merck Serono, France



• Amycor
  Merck Serono, France



• Antifungol Hexal
  Hexal, Germany



• Azolmen
  Menarini, Italy



• Biazol
  Gedeon Richter, Romania



• Bicronol
  Iwaki Seiyaku, Japan



• Bicutrin
  Srbolek, Serbia



• Bifized
  Iasis, Greece



• Bifokey
  Inkeysa, Spain



• Bifomyk
  Riemser, Germany



• Bifon
  Dermapharm, Germany; Genepharm, Georgia



• Bifonazol Aristo
  Aristo Pharma, Germany



• Bifonazol Genfar
  Genfar, Peru



• Bifonazol Hexal
  Hexal, Germany



• Bifonazol L.CH.
  Chile, Chile



• Bifonazol
  Bago, Chile



• Bifonazole
  Vitamed, Israel



• Bifonazole-Teva
  Teva, Israel



• Bifonazol-SL
  Slovakofarma, Bulgaria



• Bifonol
  Mayado Seiyaku, Japan



• Bifunal
  Actavis, Georgia; Balkanpharma, Bulgaria



• Bilmitin
  Taisho Yakuhin, Japan



• Bimicot
  Euroderm, Argentina



• Biscopor
  Ryukakusan, Japan



• Biselect
  Lindopharm, Germany



• Canesten Bifonazol
  Bayer, Austria



• Canesten Plus Bifonazol
  Bayer, Hungary



• Canesten Unidie
  Bayer, Italy



• Canesten
  Bayer, Germany; Bayer, New Zealand; Bayer Consumer Care, Australia



• Canesten Extra Nagelset (Bifonazole and Urea)
  Bayer, Germany



• Canestene Onychoset Bifonazole
  Bayer Animal Health, Luxembourg



• Canestene Derm
  Bayer, Belgium; Bayer Animal Health, Luxembourg



• Fospoal
  Sawai Seiyaku, Japan



• Fungiderm
  Biospray, Greece



• Fungotopic
  Chile, Chile



• Gloryskin
  Medimar, Greece



• Helpovion
  Medicus, Greece



• Kavaderm
  Relyo, Greece



• Lenchence
  Yoshindo, Japan



• Levelina
  Ern, Spain



• Marinzoal
  Sato Seiyaku, Japan



• Micomicen
  Labomed, Chile



• Micosol
  Pablo Cassara, Argentina



• Moldine
  Taiyo Pharmaceutical, Japan



• Multifung
  Rider, Chile



• Myco-Flusemidon
  Anfarm, Greece; Anfarm Hellas, Romania



• Mycospor Onicoset (Bifonazole and Urea)
  Bayer, Spain



• Mycospor
  Bayer, United Arab Emirates; Bayer, Netherlands Antilles; Bayer, Aruba; Bayer, Barbados; Bayer, Bahrain; Bayer, Bermuda; Bayer, Brazil; Bayer, Bahamas; Bayer, Belize; Bayer, China; Bayer, Colombia; Bayer, Costa Rica; Bayer, Cyprus; Bayer, Czech Republic; Bayer, Germany; Bayer, Dominican Republic; Bayer, Ecuador; Bayer, Egypt; Bayer, Spain; Bayer, Georgia; Bayer, Greece; Bayer, Guatemala; Bayer, Hong Kong; Bayer, Honduras; Bayer, Haiti; Bayer, Hungary; Bayer, Iran; Bayer, Jamaica; Bayer, Jordan; Bayer, Kenya; Bayer, Kuwait; Bayer, Cayman Islands; Bayer, Lebanon; Bayer, Mexico; Bayer, Nicaragua; Bayer, Netherlands; Bayer, Oman; Bayer, Panama; Bayer, Peru; Bayer, Poland; Bayer, Portugal; Bayer, Qatar; Bayer, Romania; Bayer, Russian Federation; Bayer, Saudi Arabia; Bayer, Sudan; Bayer, Slovenia; Bayer, Slovakia; Bayer, Suriname; Bayer, El Salvador; Bayer, Turkey; Bayer, Trinidad & Tobago; Bayer, Taiwan; Bayer, Tanzania; Bayer, Uganda; Bayer Animal Health, Luxembourg; Bayer Consumer Care, Australia; Bayer Schering, Indonesia; Bayer Schering, South Africa; Bayer Yakuhin, Japan



• Mycosporan
  Bayer, Chile



• Mycozole
  Kyowa Yakuhin, Japan



• Neltolon
  Pharmathen, Greece



• Rye
  Rafarm, Greece



• Sinamida
  Gezzi, Argentina



• Topical
  Tecnimede, Portugal



• Zerus
  Maeda Yakuhin, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Zink-Sandoz

Zink-Sandoz may be available in the countries listed below.

Ingredient matches for Zink-Sandoz

Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Zink-Sandoz in the following countries:

• Germany

Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Zink-Sandoz in the following countries:

• Germany

International Drug Name Search

Chloro-Sleecol

Chloro-Sleecol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chloro-Sleecol

Chloramphenicol

Chloramphenicol palmitate (a derivative of Chloramphenicol) is reported as an ingredient of Chloro-Sleecol in the following countries:

• Germany

International Drug Name Search

Bastamion

Bastamion may be available in the countries listed below.

Ingredient matches for Bastamion

Voglibose

Voglibose is reported as an ingredient of Bastamion in the following countries:

• Japan

International Drug Name Search